Adenovirus-mediated CTLA4-IgG gene therapy in orthotopic small intestinal transplantation in rats.
Echizenya
H
H
First Department of Surgery, Hokkaido University, School of Medicine, Sapporo, Japan.
Yamashita
K
K
Takehara
M
M
Konishi
K
K
Nomura
M
M
Yanagida
N
N
Kitagawa
N
N
Kobayashi
T
T
Furukawa
H
H
Inobe
M
M
Uede
T
T
Todo
S
S
D000069594:Abatacept; D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000097:blood / Q000627:therapeutic use*; D018122:B7-1 Antigen / Q000187:drug effects*; D018106:CD28 Antigens / Q000187:drug effects*; D060908:CTLA-4 Antigen; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000627:therapeutic use*; D006084:Graft Rejection / Q000097:blood / Q000517:prevention & control; D018796:Immunoconjugates; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000097:blood / Q000627:therapeutic use*; D007421:Intestine, Small / Q000637:transplantation*; D008297:Male; D051381:Rats; D011917:Rats, Inbred Lew
D015703:Antigens, CD; D000943:Antigens, Differentiation; D018122:B7-1 Antigen; D018106:CD28 Antigens; D060908:CTLA-4 Antigen; D018796:Immunoconjugates; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D000069594:Abatacept